Proposed changes ICER 2023 value assessment framework

Since 2006, the Institute for Clinical and Economic Review (ICER) in the United States has assessed the clinical and economic value of innovative medical technologies and made pricing recommendations with the goal of achieving “sustainable access to highly effective treatments for all patients”. The...

Full description

Saved in:
Bibliographic Details
Main Authors: I. R. Svechkareva, A. A. Kurylev
Format: Article
Language:Russian
Published: Publishing House OKI 2023-12-01
Series:Реальная клиническая практика: данные и доказательства
Subjects:
Online Access:https://www.myrwd.ru/jour/article/view/50
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248664830083072
author I. R. Svechkareva
A. A. Kurylev
author_facet I. R. Svechkareva
A. A. Kurylev
author_sort I. R. Svechkareva
collection DOAJ
description Since 2006, the Institute for Clinical and Economic Review (ICER) in the United States has assessed the clinical and economic value of innovative medical technologies and made pricing recommendations with the goal of achieving “sustainable access to highly effective treatments for all patients”. The methodological framework developed by ICER assesses the longterm economic value of health interventions and their availability in the shortest possible time.
format Article
id doaj-art-996a7483d97144faab2a56ba82f39405
institution Kabale University
issn 2782-3784
language Russian
publishDate 2023-12-01
publisher Publishing House OKI
record_format Article
series Реальная клиническая практика: данные и доказательства
spelling doaj-art-996a7483d97144faab2a56ba82f394052025-08-20T03:57:48ZrusPublishing House OKIРеальная клиническая практика: данные и доказательства2782-37842023-12-0134222810.37489/2782-3784-myrwd-4448Proposed changes ICER 2023 value assessment frameworkI. R. Svechkareva0A. A. Kurylev1FSBEI HE First St. Petersburg State Medical University named after I.P. PavlovFSBEI HE First St. Petersburg State Medical University named after I.P. Pavlov; FSBI National Research Center of Oncology named after N.N. Petrov of the Ministry of Health of RussiaSince 2006, the Institute for Clinical and Economic Review (ICER) in the United States has assessed the clinical and economic value of innovative medical technologies and made pricing recommendations with the goal of achieving “sustainable access to highly effective treatments for all patients”. The methodological framework developed by ICER assesses the longterm economic value of health interventions and their availability in the shortest possible time.https://www.myrwd.ru/jour/article/view/50clinical researchhealth technology assessmentpricingdemographic categoriescomparative clinical effectiveness
spellingShingle I. R. Svechkareva
A. A. Kurylev
Proposed changes ICER 2023 value assessment framework
Реальная клиническая практика: данные и доказательства
clinical research
health technology assessment
pricing
demographic categories
comparative clinical effectiveness
title Proposed changes ICER 2023 value assessment framework
title_full Proposed changes ICER 2023 value assessment framework
title_fullStr Proposed changes ICER 2023 value assessment framework
title_full_unstemmed Proposed changes ICER 2023 value assessment framework
title_short Proposed changes ICER 2023 value assessment framework
title_sort proposed changes icer 2023 value assessment framework
topic clinical research
health technology assessment
pricing
demographic categories
comparative clinical effectiveness
url https://www.myrwd.ru/jour/article/view/50
work_keys_str_mv AT irsvechkareva proposedchangesicer2023valueassessmentframework
AT aakurylev proposedchangesicer2023valueassessmentframework